Please login to the form below

Not currently logged in
Email:
Password:

Optum

This page shows the latest Optum news and features for those working in and with pharma, biotech and healthcare.

Health insurers will test blockchain for data handling

Health insurers will test blockchain for data handling

The healthcare payers - Humana, UnitedHealthcare and Optum - have joined forces with lab testing firm Quest Diagnostics and cost-management specialist MultiPlan to pilot the use of blockchain to “improve data quality

Latest news

  • Ex-GSK CEO Witty named head of pharmacy benefit firm Optum Ex-GSK CEO Witty named head of pharmacy benefit firm Optum

    Former GlaxoSmithKline chief executive Andrew Witty has been named as the new head of UnitedHealth’s pharmacy benefit manager Optum. ... will now be on the other side of the fence at the helm of Optum from July 1.

  • Amazon's healthcare move takes aim at US costs Amazon's healthcare move takes aim at US costs

    UnitedHealth, the biggest health insurer in the US, saw its stock fall 7.1% and its recently acquired health services unit Optum was also down 5%.

  • Sanofi sets up diabetes joint venture with Google's Verily Sanofi sets up diabetes joint venture with Google's Verily

    Onduo is being headed up by Joshua Riff, a medic by training who has previously held senior roles at health services company Optum, part of United Healthcare, and the Target group.

  • Mobile health roundup

    Optum has launched a ' health care cloud' service that aims to help healthcare professionals communicate with each other and their patients through secure text and video chat. ... By providing a secure place where more people can contribute to the

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics